{
    "organizations": [],
    "uuid": "8b3888dc19cd9ea56ef62f2a00cbb95a02303779",
    "author": "",
    "url": "https://www.reuters.com/article/brief-erytech-to-present-results-from-ph/brief-erytech-to-present-results-from-phase-i-trial-of-eryaspase-in-all-and-new-pre-clinical-data-at-aacr-2018-idUSASC09VMU",
    "ord_in_thread": 0,
    "title": "BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Market News April 12, 2018 / 10:18 AM / Updated 11 minutes ago BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018 Reuters Staff 1 Min Read \nApril 12 (Reuters) - Erytech Pharma SA: \n* ERYTECH TO PRESENT RESULTS FROM PHASE I TRIAL OF ERYASPASE IN ALL AND NEW PRE-CLINICAL DATA AT AACR 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-04-12T13:16:00.000+03:00",
    "crawled": "2018-04-12T13:38:35.082+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "market",
        "news",
        "april",
        "updated",
        "minute",
        "ago",
        "present",
        "result",
        "phase",
        "trial",
        "eryaspase",
        "new",
        "pre",
        "clinical",
        "data",
        "aacr",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "erytech",
        "pharma",
        "sa",
        "erytech",
        "present",
        "result",
        "phase",
        "trial",
        "eryaspase",
        "new",
        "data",
        "aacr",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}